Next level flexibilty for drug discovery

Malvern Analytics sheds light on the challenges that remain in using kinetic analysis for the early stages of drug discovery. Discover how the WAVEsystem, a Creoptix^® technology, tackles these challenges by using the inherent sensitivity of the grating-coupled interferometry (GCI) detection principle and use of non-clog WAVEchips^®. Explore the method by which the system has addressed these difficulties, along with examples of how it has been successful in doing so.